We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
-7.31%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.64B
AUM Growth
-$239M
Cap. Flow
-$76.2M
Cap. Flow %
-4.65%
Top 10 Hldgs %
45.73%
Holding
139
New
1
Increased
10
Reduced
53
Closed
1

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.24M
2
CRNC icon
Cerence
CRNC
+$315K
3
ZIMV
ZimVie
ZIMV
+$250K
4
CALX icon
Calix
CALX
+$157K
5
KFY icon
Korn Ferry
KFY
+$119K

Top Sells

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$11.3M
2
SCHW
Charles Schwab
SCHW
+$9.32M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$9.31M
4
SNPS icon
Synopsys
SNPS
+$6.55M
5
MSFT icon
Microsoft
MSFT
+$4.15M

Sector Composition

Rank Sector Weight
1 Technology 41.59%
2 Communication Services 15%
3 Healthcare 14.31%
4 Consumer Discretionary 14.29%
5 Financials 11.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DKNG icon
51
DraftKings
DKNG
$12.2B
$5.16M 0.32%
265,193
-5,425
-2% -$115K
UNH icon
52
UnitedHealth
UNH
$382B
$4.72M 0.29%
9,250
– –
TMHC
53
DELISTED
Taylor Morrison
TMHC
$4.5M 0.27%
165,404
-7,216
-4% -$220K
DGX icon
54
Quest Diagnostics
DGX
$26B
$4.31M 0.26%
31,480
– –
KLIC icon
55
Kulicke & Soffa
KLIC
$4.34B
$3.97M 0.24%
70,838
– –
CRUS icon
56
Cirrus Logic
CRUS
$6.76B
$3.86M 0.24%
45,563
– –
SEDG icon
57
SolarEdge
SEDG
$2.37B
$3.67M 0.22%
11,368
– –
IBM icon
58
IBM
IBM
$213B
$3.58M 0.22%
27,546
-861
-3% -$112K
ELV icon
59
Elevance Health
ELV
$81.5B
$3.38M 0.21%
6,877
– –
AEIS icon
60
Advanced Energy
AEIS
$10.1B
$3.2M 0.2%
37,155
+1,353
+4% +$117K
JKHY icon
61
Jack Henry & Associates
JKHY
$11.4B
$3.14M 0.19%
15,925
– –
UTHR icon
62
United Therapeutics
UTHR
$26.1B
$3.1M 0.19%
17,260
– –
CI icon
63
Cigna
CI
$78.4B
$2.99M 0.18%
12,492
– –
DIOD icon
64
Diodes
DIOD
$3.5B
$2.88M 0.18%
33,070
– –
JAZZ icon
65
Jazz Pharmaceuticals
JAZZ
$16.1B
$2.81M 0.17%
18,050
– –
COR icon
66
Cencora
COR
$62B
$2.7M 0.16%
17,440
– –
NXGN
67
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$2.63M 0.16%
125,660
– –
SIMO icon
68
Silicon Motion
SIMO
$7.11B
$2.62M 0.16%
39,269
– –
PEP icon
69
PepsiCo
PEP
$196B
$2.58M 0.16%
15,414
-3,290
-18% -$552K
NDSN icon
70
Nordson
NDSN
$16.4B
$2.58M 0.16%
11,354
– –
PANW icon
71
Palo Alto Networks
PANW
$256B
$2.57M 0.16%
24,780
– –
REGN icon
72
Regeneron Pharmaceuticals
REGN
$72.9B
$2.5M 0.15%
3,575
– –
SYK icon
73
Stryker
SYK
$135B
$2.46M 0.15%
9,215
– –
COHU icon
74
Cohu
COHU
$1.86B
$2.42M 0.15%
81,652
– –
CTXS
75
DELISTED
Citrix Systems Inc
CTXS
$2.32M 0.14%
22,990
-35,000
-60% -$3.54M
1 2
3
4 5

Similar funds

FAT
First American Trust Santa Ana, California $1.49B AUM 21.98% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
LFS
Lutz Financial Services Omaha, Nebraska $1.49B AUM 10.4% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.49B AUM 28.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Oak Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Oak Associates held 139 positions worth $1.64B, down 13% from $1.88B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Oak Associates withdrew a net $76.2M in Q1 2022, closing 1 position and reducing 53 holdings. Its most notable exit was CyrusOne Inc Common Stock, an estimated $403K position sold in full.

By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 42% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Oak Associates opened a new position in ZimVie worth $242K.

  • Oak Associates's largest Q1 2022 buy was ZimVie: 10,616 shares worth $242K.
  • Oak Associates added most to Pfizer in Q1 2022, an estimated $1.24M increase.
  • Oak Associates's biggest Q1 2022 reduction was KLA, cutting an estimated $11.3M.
  • Oak Associates fully exited CyrusOne Inc Common Stock in Q1 2022, selling an estimated $403K.
  • Oak Associates's ten largest holdings make up 46% of its $1.64B portfolio in Q1 2022.
  • Oak Associates opened 1 new position and closed 1 in Q1 2022.
  • Oak Associates's portfolio value fell 13% quarter-over-quarter to $1.64B.

Based on Oak Associates's 13F filing for Q1 2022, filed 12 May 2022.